As of 2025-07-16, the EV/EBITDA ratio of Akoya Biosciences Inc (AKYA) is -4.07. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AKYA's latest enterprise value is 121.60 mil USD. AKYA's TTM EBITDA according to its financial statements is -29.88 mil USD. Dividing these 2 quantities gives us the above AKYA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.2x - 15.7x | 13.9x |
| Forward P/E multiples | 15.7x - 16.8x | 16.4x |
| Fair Price | (10.58) - (10.55) | (10.21) |
| Upside | -920.0% - -918.1% | -891.4% |
| Date | EV/EBITDA |
| 2025-07-07 | -4.07 |
| 2025-07-03 | -4.19 |
| 2025-07-02 | -4.17 |
| 2025-07-01 | -4.12 |
| 2025-06-30 | -4.09 |
| 2025-06-27 | -3.99 |
| 2025-06-26 | -4.14 |
| 2025-06-25 | -4.05 |
| 2025-06-24 | -4.00 |
| 2025-06-23 | -4.07 |
| 2025-06-20 | -4.02 |
| 2025-06-18 | -4.09 |
| 2025-06-17 | -4.00 |
| 2025-06-16 | -4.04 |
| 2025-06-13 | -3.97 |
| 2025-06-12 | -4.02 |
| 2025-06-11 | -4.12 |
| 2025-06-10 | -4.14 |
| 2025-06-09 | -3.79 |
| 2025-06-06 | -3.85 |
| 2025-06-05 | -3.82 |
| 2025-06-04 | -3.85 |
| 2025-06-03 | -3.82 |
| 2025-06-02 | -4.00 |
| 2025-05-30 | -4.00 |
| 2025-05-29 | -3.99 |
| 2025-05-28 | -3.95 |
| 2025-05-27 | -4.04 |
| 2025-05-23 | -4.02 |
| 2025-05-22 | -4.09 |
| 2025-05-21 | -4.09 |
| 2025-05-20 | -3.69 |
| 2025-05-19 | -3.67 |
| 2025-05-16 | -3.64 |
| 2025-05-15 | -3.58 |
| 2025-05-14 | -3.49 |
| 2025-05-13 | -3.61 |
| 2025-05-12 | -3.85 |
| 2025-05-09 | -3.75 |
| 2025-05-08 | -3.82 |
| 2025-05-07 | -3.79 |
| 2025-05-06 | -3.80 |
| 2025-05-05 | -4.00 |
| 2025-05-02 | -3.95 |
| 2025-05-01 | -3.94 |
| 2025-04-30 | -3.92 |
| 2025-04-29 | -4.04 |
| 2025-04-28 | -4.10 |
| 2025-04-25 | -4.09 |
| 2025-04-24 | -4.04 |